The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students
Clinical trial NCT06208683 · UNKNOWN
Trial details
- NCT number
- NCT06208683
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-04
- Primary completion
- 2024-02-02
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.